GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's special charges for the three months ended in Jun. 2014 was $0.00 Mil. Its special charges for the trailing twelve months (TTM) ended in Jun. 2014 was $0.00 Mil.
It is nonrecurring losses or expenses resulting from transactions or events which, in the view of management, are not representative of normal business activities of the period and which affect comparability of earnings.
Synageva BioPharma Corp SpecialCharges for the trailing twelve months (TTM) ended in Jun. 2014 was 0 (Sep. 2013 ) + 0 (Dec. 2013 ) + 0 (Mar. 2014 ) + 0 (Jun. 2014 ) = $0.00 Mil.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data